Nuri Onat Demirci
Nuri Onat Demirci
Medicalpark Göztepe Hastanesi
medicalpark.com.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis
T Avsar, D Korkmaz, M Tütüncü, NO Demirci, S Saip, M Kamasak, A Siva, ...
Multiple Sclerosis Journal 18 (8), 1081-1091, 2012
452012
Infliximab is a plausible alternative for neurologic complications of Behçet disease
B Zeydan, U Uygunoglu, S Saip, ON Demirci, E Seyahi, S Ugurlu, ...
Neurology-Neuroimmunology Neuroinflammation 3 (5), 2016
342016
Chronic cerebrospinal venous insufficiency: does ultrasound really distinguish multiple sclerosis subjects from healthy controls?
F Kantarci, S Albayram, NO Demirci, A Esenkaya, D Uluduz, O Uysal, ...
European radiology 22 (5), 970-979, 2012
152012
Brief repeatable battery (BRB)-Turkish normative data
A Bingol, S Yildiz, B Topçular, M Tutuncu, NO Demirci, U Uygunoglu, ...
WILEY-BLACKWELL, 2012
92012
CSF proteomics identifies specific and shared pathways for multiple sclerosis clinical subtypes
T Avsar, İM Durası, U Uygunoğlu, M Tütüncü, NO Demirci, S Saip, ...
PloS one 10 (5), e0122045, 2015
72015
Cognitive dysfunction in multiple sclerosis in a Turkish cohort
A Bingol, S Yidiz, M Tutuncu, NO Demirci, N Ahi, B Topçular, S Saip, ...
JOURNAL OF NEUROLOGY 257, S186-S187, 2010
32010
Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Turkish
A Bingol, B Topcular, S Yildiz, M Tutuncu, O Demirci, S Saip, A Siva
MULTIPLE SCLEROSIS JOURNAL 17, S401-S401, 2011
22011
A patient with established primary progressive multiple sclerosis transitions to ‘secondary’relapsing–remitting disease course following a fulminant demyelinating episode
M Tutuncu, NO Demirci, F Özer, S Saip, OH Kantarci, A Siva
Multiple Sclerosis Journal 17 (10), 1262-1264, 2011
22011
What are the predictors of disease progression in Turkish Multiple Sclerosis patients.(4702)
NO Demirci, M Tutuncu, U Uygunoğlu, S Saip, A Siva
Neurology 94 (15 Supplement), 2020
2020
Infliximab for Treatment Refractory Neuro-Behçet Syndrome (P2. 161)
B Zeydan, U Uygunoglu, S Saip, O Demirci, E Seyahi, S Ugurlu, ...
Neurology 86 (16 Supplement), 2016
2016
Proteomic Analysis in CSF Identified Subtype Specific and Shared Molecular Pathways for Multiple Sclerosis Clinical Phenotypes (P5. 216)
T Avsar, İ Durasi, U Uygunoglu, M Tutuncu, N Demirci, S Saipoglu, ...
Neurology 84 (14 Supplement), 2015
2015
Clinical follow-up of neuro-Behcet syndrome patients treated with infliximab
B Zeydan, NO Demirci, U Uygunoglu, E Seyahi, S Ugurlu, S Saip, A Siva
JOURNAL OF NEUROLOGY 260, S113-S114, 2013
2013
Impact of depression on quality of life in multiple sclerosis patients
A Bingol, E Goksel, S Yildiz, U Uygunoglu, NO Demirci, A Altintas, S Saip, ...
MULTIPLE SCLEROSIS JOURNAL 18, 489-490, 2012
2012
Proteomic analysis: identification of candidate protein biomarkers in the CSF and serum samples of patients with clinically different multiple sclerosis subtypes
T Avsar, U Uygunoglu, M Tutuncu, NO Demirci, S Saip, A Siva, ET Turanli
MULTIPLE SCLEROSIS JOURNAL 18, 263-264, 2012
2012
Long-term effects of cognitive rehabilitation in multiple sclerosis: six months follow-up
B Topcular, A Bingol, S Yildiz, M Tutuncu, O Demirci, S Saip, A Siva
MULTIPLE SCLEROSIS JOURNAL 17, S173-S174, 2011
2011
Is cognitive dysfunction in multiple sclerosis and Neuro-Behçet's disease similar?: P439
A Bingol, B Topcular, S Yildiz, P Kaya, M Tutuncu, O Demirci, D Uluduz, ...
Journal of Neurology 258, 2011
2011
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–16